A caveat for T cell transfer studies: Generation of cytotoxic anti-Thy1.2 antibodies in Thy1.1 congenic mice given Thy1.2+ tumors or T cells

Journal of Leukocyte Biology

Volumn 89, Issue 2, 2011, Pages 291-300

  McKenna, Kyle C ^a   Miguel, Rodolfo D Vicetti ^a   Beatty, Kelly M ^a   Bilonick, Richard A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adoptive transfer; Antibody; CD90

Indexed keywords

CYTOTOXIC ANTIBODY; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CANCER GRAFT; CONGENIC STRAIN; CONTROLLED STUDY; EYE TUMOR; FEMALE; GENE DELETION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE TRANSFER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, THY-1; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOMA, T-CELL; MALE; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 79951844224     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0610333     Document Type: Article

References (30)

1. Zajac, A. J., Blattman, J. N., Murali-Krishna, J., Sourdive, D. J. D., Suresh, M., Altman, J. D., Ahmed, R. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213. (Pubitemid 29028493)
2. McKenna, K. C., Xu, Y., Kapp, J. A. (2002) Injection of soluble antigen into the anterior chamber of the eye induces expansion and functional unresponsiveness of antigen-specific CD8+ T cells. J. Immunol. 169, 5630-5637.
3. McKenna, K. C., Anderson, K. M., Kapp, J. A. (2005) CD8+ T-cell tolerance induced by delivery of antigen to the anterior chamber is not the result of de facto intravenous or mucosal administration of antigen. Ocul. Immunol. Inflamm. 13, 149-157.
4. Shrikant, P., Mescher, M. (1999) Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J. Immunol. 162, 2858-2866. (Pubitemid 29309312)
5. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., Davis, M. M. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96. (Pubitemid 26332731)
6. Chen, W., Cheever, M. A. (1994) Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression. J. Immunol. 152, 4767-4774. (Pubitemid 24139068)
7. Li, X., Wang, Y., Urso, D., O'Rourke, J., Cone, R. E. (2004) Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies. Immunology 113, 44-56. (Pubitemid 39178843)
8. Moore, M. W., Carbone, F. R., Bevan, M. J. (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785.
9. Hollenbaugh, J. A., Reome, J., Dobrzanski, M., Dutton, R. W. (2004) The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis. J. Immunol. 173, 1738-1743. (Pubitemid 38971605)
10. McKenna, K. C., Kapp, J. A. (2006) Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye. J. Immunol. 177, 1599-1608. (Pubitemid 44092495)
11. Sha, W. C., Nelson, C. A., Newberry, R. D., Kranz, D. M., Russell, J. H., Loh, D. Y. (1988) Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335, 271-274.
12. R Development Core Team (2009) A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna Austria, http://www.R-project.org.
13. Pinheiro, J., Bates, D., Debroy, S., Sarkar, D., R Core Team (2009) nlme: Linear and Nonlinear Mixed Effects Models, R Package, version 3, 1-96.
14. Hollenbaugh, J. A., Dutton, R. W. (2006) IFN-γ regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. J. Immunol. 177, 3004-3011. (Pubitemid 44277816)
15. Williams, A. F., Gagnon, J. (1982) Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin. Science 216, 696-703. (Pubitemid 12041767)
16. Barber, D. L., Wherry, E. J., Ahmed, R. (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171, 27-31. (Pubitemid 36745269)
17. Byers, A. M., Kemball, C. C., Moser, J. M., Lukacher, A. E. (2003) Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J. Immunol. 171, 17-21. (Pubitemid 36745267)
18. Lake, P., Douglas, T. C. (1978) Recognition and genetic control of helper determinants for cell surface antigen Thy-1. Nature 275, 220-222. (Pubitemid 9008033)
19. Gorzynski, T., Zaleski, M. B. (1979) Recognition of the Thy-1.2 antigen in the context of the H-2 antigens. Transplantation 28, 159-161. (Pubitemid 9247290)
20. Niederkorn, J. Y., Streilein, J. W. (1982) Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye. Transplantation 33, 573-577. (Pubitemid 12079022)
21. Niederkorn, J. Y., Streilein, J. W. (1983) Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge. J. Immunol. 131, 2587-2594. (Pubitemid 14230102)
22. Cochran, A. J., Foulds, W. S., Damato, B. E., Trope, G. E., Morrison, L., Lee, W. R. (1985) Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma. Br. J. Ophthalmol. 69, 171-176. (Pubitemid 15147023)
23. Sohn, J. H., Kaplan, H. J., Suk, H. J., Bora, P. S., Bora, N. S. (2000) Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest. Ophthalmol. Vis. Sci. 41, 4195-4202.
24. Goslings, W. R., Blom, D. J., de Waard-Siebinga, I., van Beelan, E., Claas, F. H., Jager, M. J., Gorter, A. (1996) Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas. Invest. Ophthalmol. Vis. Sci. 37, 1884-1891. (Pubitemid 26265040)
25. Skundric, D. S., Huston, K., Shaw, M., Tse, H. Y., Raine, C. S. (1994) Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Lab. Invest. 71, 671-679. (Pubitemid 24374574)
26. Clark, E. A., Lake, P., Favila-Castillo, L. (1981) Modulation of Thy-1 alloantibody responses: donor cell-associated H-2 inhibition and augmentation without recipient Ir gene control. J. Immunol. 127, 2135-2140. (Pubitemid 11023212)
27. Zhou, P., Reichner, J. S., Gorzynski, Quackenbuch, L. J., Zaleski, M. B. (1989) Evidence that class I-restricted response to Thy-1 antigen requires L3T4+ cells and macrophages but not Lyt-2+ cells. Transplantation 47, 1089-1092.
28. Beyer, C., Pisetsky, D. S. (2010) The role of microparticles in the pathogenesis of rheumatic diseases. Nat. Rev. Rheumatol. 6, 21-29.
29. D'Orazio, T. J., Mayhew, E., Niederkorn, J. Y. (2001) Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166, 26-32. (Pubitemid 32038413)
30. Sellam, J., Proulle, V., Jungel, A., Ittah, M., Miceli, R. C., Gottenberg, J. E., Toti, F., Benessiano, J., Gay, S., Freyssinet, J. M., Mariette, X. (2009) Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res. Ther. 11, R156.